GlassScriptPhysician profile
Alexis Agustine Vazquez
NPI 1518909167
$18,342.88
in general payments reported to CMS, 2019-2025
48 companies · $3,063 in 2025
The $3,063 reported for 2025 was more than what 83% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,342 · 2020: $1,717 · 2021: $2,376 · 2022: $3,211 · 2023: $2,619 · 2024: $3,016 · 2025: $3,063.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,696.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,450.34 | 2019-2025 | Airsupra, Tezspire, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,110.15 | 2019-2025 | Ofev, Jascayd, Stiolto Respimat |
| Regeneron Healthcare Solutions, INC. | $1,387.57 | 2019-2025 | Dupixent |
| Genzyme Corporation | $1,140.66 | 2019-2025 | |
| Grifols USA, LLC | $1,094.80 | 2019-2024 | Prolastin-C Liquid |
| Glaxosmithkline, LLC. | $820.21 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $814.30 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Amgen INC. | $700.68 | 2021-2024 | Tezspire |
| Insmed, INC. | $682.99 | 2019-2025 | Arikayce, Brinsupri |
| Baxter Healthcare | $628.41 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Takeda Pharmaceuticals U.S.A., INC. | $598.73 | 2021-2025 | Glassia |
| Philips North America LLC | $556.29 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Mylan Specialty L.P. | $520.29 | 2019-2024 | Yupelri |
| Inogen, INC. | $495.77 | 2021-2025 | Inogen |
| Mallinckrodt Hospital Products INC. | $455.90 | 2020-2025 | Acthar |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $347.85 | 2019-2025 | Winrevair, Keytruda |
| Electromed, INC. | $323.89 | 2021-2024 | Smartvest |
| Ani Pharmaceuticals, INC. | $286.08 | 2023-2025 | Purified Cortrophin Gel |
| Axsome Therapeutics, INC. | $257.83 | 2022-2025 | Sunosi |
| Bayer Healthcare Pharmaceuticals INC. | $178.93 | 2019-2023 | |
| Viatris Specialty LLC | $152.85 | 2025 | Yupelri |
| Sunovion Pharmaceuticals INC. | $148.36 | 2019-2020 | |
| Genentech USA, INC. | $144.53 | 2019-2022 | |
| Pulmonx Corporation | $110.76 | 2022-2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Paratek Pharmaceuticals, INC. | $96.20 | 2023-2025 | Nuzyra |
| Fisher & Paykel Healthcare INC | $89.69 | 2020-2024 | Fisher & Paykel Healthcare |
| Allergan, INC. | $85.56 | 2019-2020 | |
| 3b Medical, INC. | $61.42 | 2024 | Luna |
| Circassia INC. | $57.85 | 2019-2020 | |
| Optinose US, INC. | $55.29 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $46.13 | 2019 | |
| Alexion Pharmaceuticals, INC. | $45.38 | 2021-2022 | |
| Pfizer INC. | $44.26 | 2022-2023 | |
| Advanced Respiratory, INC | $43.86 | 2021 | |
| Novartis Pharmaceuticals Corporation | $40.30 | 2019-2025 | |
| Abbvie INC. | $38.88 | 2021-2024 | |
| Alk-Abello, INC | $26.85 | 2025 | Odactra, Ragwitek, Grastek |
| Gilead Sciences, INC. | $24.46 | 2021 | |
| Verona Pharma, INC. | $22.96 | 2025 | Ohtuvayre |
| Jazz Pharmaceuticals INC. | $22.45 | 2021 | |
| Lilly USA, LLC | $21.94 | 2025 | Zepbound |
| Abiomed | $21.90 | 2023 | Impella |
| Inspire Medical Systems, INC. | $21.34 | 2025 | Inspire |
| United Therapeutics Corporation | $17.21 | 2021 | |
| Sandoz INC. | $17.01 | 2025 | Treprostinil |
| Shire North American Group INC | $12.21 | 2019 | |
| Ethicon INC. | $11.39 | 2020 | |
| Veran Medical Technologies, INC. | $10.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexis Vazquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.